Scores are 0 to 100 against every US stock we track; 50 is average. Recomputed after every US market close.
Fiscal year to December 2025, from the company's annual filing with the SEC.
| Salesyearly sales | $7.5B |
| Sales growthchange from the year before | +0.8% |
| Operating marginshare of sales left after running the business | 2.9% |
| Net marginshare of sales kept as profit | 0.9% |
| Return on invested capitalprofit made on each $100 put into the business | 1.9% |
| Return on equityprofit vs. shareholders' accounting value | 0.9% |
| Debt / equitydebt vs. shareholders' accounting value | 0.25 |
| Change in share countnegative = the company is buying back its shares | +0.3% |
2 insiders sold $3.8M on the open market.
| Flanagan Cary MExec VP and CAO | SoldJul 31 | 3,600 shat $70.82 · $255K |
| Dove ReidDirector | SoldJul 31 | 50,000 shat $70.25 · $3.5M |
From Form 4 filings with the SEC. Open-market trades only. "Plan" = a sale set up in advance under a 10b5-1 plan, usually routine.
Not financial advice. Research and education only: the same view for everyone, with no regard to your circumstances. Past results do not predict future ones. Decide for yourself or with a licensed adviser. Terms · Privacy